CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.51%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$7.52B
AUM Growth
+$1.2B
(+19%)
Cap. Flow
+$733M
Cap. Flow
% of AUM
9.75%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
870
New
79
Increased
318
Reduced
279
Closed
56
Top Buys
| 1 |
Amgen
AMGN
|
+$78.9M |
| 2 |
Biogen
BIIB
|
+$72.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$63.8M |
| 4 |
Merck
MRK
|
+$58M |
| 5 |
Gilead Sciences
GILD
|
+$33.8M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
+$26.1M |
| 2 |
iRobot
IRBT
|
+$15.5M |
| 3 |
Quest Diagnostics
DGX
|
+$15.1M |
| 4 |
Colgate-Palmolive
CL
|
+$14.9M |
| 5 |
Philip Morris
PM
|
+$12.2M |
Sector Composition
| 1 | Healthcare | 33.27% |
| 2 | Technology | 16.05% |
| 3 | Financials | 11.26% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Assurant
AIZ
$10.7B
| $1.37M | 0.02% |
12,643
-88,402
| -87% | -$9.54M |
|
|
SRNE
552
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.36M | 0.02% |
310,000
| – | – |
|
553
Cheniere Energy
LNG
$51.3B
| $1.35M | 0.02% |
19,429
| – | – |
|
554
Equifax
EFX
$31.2B
| $1.35M | 0.02% |
10,320
| – | – |
|
|
TWTR
555
DELISTED
Twitter, Inc.
TWTR
| $1.34M | 0.02% |
47,101
+1,690
| +4% | +$48.1K |
|
556
Macy's
M
$4.57B
| $1.34M | 0.02% |
38,461
+4,758
| +14% | +$165K |
|
557
Mesa Laboratories
MLAB
$351M
| $1.34M | 0.02% |
7,200
| – | – |
|
558
Esperion Therapeutics
ESPR
$512M
| $1.33M | 0.02% |
30,000
| – | – |
|
559
BioLife Solutions
BLFS
$1.26B
| $1.33M | 0.02% |
+76,000
| New | +$1.33M |
|
|
DISCA
560
DELISTED
Discovery, Inc. Series A Common Stock
DISCA
| $1.33M | 0.02% |
41,565
| – | – |
|
561
Ardelyx
ARDX
$1.59B
| $1.31M | 0.02% |
300,000
| – | – |
|
562
Targa Resources
TRGP
$34.5B
| $1.3M | 0.02% |
22,990
-516
| -2% | -$29.1K |
|
563
Workday
WDAY
$61.9B
| $1.28M | 0.02% |
8,782
+368
| +4% | +$53.7K |
|
|
ABMD
564
DELISTED
Abiomed Inc
ABMD
| $1.28M | 0.02% |
2,840
+147
| +5% | +$66.1K |
|
565
J.M. Smucker
SJM
$11.8B
| $1.27M | 0.02% |
12,378
+2,910
| +31% | +$299K |
|
566
CoStar Group
CSGP
$37.3B
| $1.26M | 0.02% |
+29,870
| New | +$1.26M |
|
567
Vulcan Materials
VMC
$39.5B
| $1.24M | 0.02% |
11,182
+930
| +9% | +$103K |
|
568
Robert Half
RHI
$3.66B
| $1.23M | 0.02% |
17,473
+3,154
| +22% | +$222K |
|
|
SRRA
569
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.22M | 0.02% |
18,000
| – | – |
|
570
AngioDynamics
ANGO
$443M
| $1.22M | 0.02% |
56,000
| – | – |
|
|
DISCK
571
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $1.21M | 0.02% |
41,006
-556
| -1% | -$16.4K |
|
572
Healthpeak Properties
DOC
$12.7B
| $1.21M | 0.02% |
45,900
+1,770
| +4% | +$46.6K |
|
573
Regency Centers
REG
$13.3B
| $1.2M | 0.02% |
18,583
+1,903
| +11% | +$123K |
|
|
GHDX
574
DELISTED
Genomic Health, Inc.
GHDX
| $1.19M | 0.02% |
17,000
-23,000
| -58% | -$1.62M |
|
575
MSCI
MSCI
$44.5B
| $1.19M | 0.02% |
+6,716
| New | +$1.19M |
|